Carderock Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$4.61M |
| 2 |
Steris
STE
|
+$4.13M |
| 3 |
Idexx Laboratories
IDXX
|
+$2.03M |
| 4 |
Roper Technologies
ROP
|
+$1.78M |
| 5 |
S&P Global
SPGI
|
+$1.77M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$1.53M |
| 2 |
Pool Corp
POOL
|
+$1.52M |
| 3 |
Mettler-Toledo International
MTD
|
+$680K |
| 4 |
Danaher
DHR
|
+$625K |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$451K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Industrials | 22.38% |
| 3 | Healthcare | 13.49% |
| 4 | Financials | 12.79% |
| 5 | Consumer Discretionary | 5.26% |
Similar funds
Carderock Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Carderock Capital Management held 62 positions worth $362M, up 22% from $298M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Carderock Capital Management deployed $28.6M of net new capital in Q4 2023, opening 5 new positions and adding to 37 existing holdings. Its largest new stake was West Pharmaceutical: 13,033 shares worth $4.59M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Pool Corp, an estimated $1.52M trimmed.
- Carderock Capital Management's largest Q4 2023 buy was West Pharmaceutical: 13,033 shares worth $4.59M.
- Carderock Capital Management added most to Idexx Laboratories in Q4 2023, an estimated $2.03M increase.
- Carderock Capital Management's biggest Q4 2023 reduction was Pool Corp, cutting an estimated $1.52M.
- Carderock Capital Management fully exited Enphase Energy in Q4 2023, selling an estimated $1.53M.
- Carderock Capital Management's ten largest holdings make up 31% of its $362M portfolio in Q4 2023.
- Carderock Capital Management opened 5 new positions and closed 1 in Q4 2023.
- Carderock Capital Management's portfolio value rose 22% quarter-over-quarter to $362M.
Based on Carderock Capital Management's 13F filing for Q4 2023, filed 23 Jan 2024.